Journal profile · Medicine-Pharmacology (medical)
ACS Pharmacology & Translational Science
ISSN 2575-9108 · American Chemical Society · UNITED STATES · Monthly · Founded 2018
ACS Pharmacology & Translational Science: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4 (journal website); transformative journal; APC about USD 4,500; median 98 days to acceptance (120 articles, last 24 months); 333 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
ACS Pharmacology & Translational Science is published by American Chemical Society and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Academic Writing and Publishing and Computational Drug Discovery Methods, together about 24.1% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
ACS Pharmacology & Translational Science reports advances in molecular and biological science, from basic and preclinical studies to clinical trials.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pharmacology (medical)
Editor-in-chief Christa E. MüllerPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology10.1%
- Academic Writing and PublishingArts and Humanities7.4%
- Computational Drug Discovery MethodsComputer Science6.6%
- Neuropeptides and Animal PhysiologyNeuroscience6.3%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.5%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.4%
- Psychedelics and Drug StudiesPsychology4.4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 5.2LetPub ·
- CiteScore (publisher)
- 5.2Publisher website ·
- SJR 2026-06
- 0.94LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 540OpenAlex ·
- 2-year mean citedness
- 4.56OpenAlex ·
- Self-citation rate
- 2.5%LetPub ·
- Share of gold OA articles
- 32.57%LetPub ·
Volume
- Articles per year
- 292LetPub ·
Articles by year OpenAlex count · 1,644 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 207 | 163 | 84 |
| 2025 | 333 | 297 | 1,063 |
| 2024 | 335 | 315 | 2,846 |
| 2023 | 179 | 161 | 2,138 |
| 2022 | 158 | 134 | 2,320 |
| 2021 | 170 | 150 | 4,500 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
98 daysMedian, submission to acceptance · P25–P75 67 days – 148 days
- Acceptance to online
- median 10 days (120 articles)
- Submission to online
- median 111 days
- Sample
- 120 articles with submission and acceptance dates (582 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Transformative journalLetPub
A subscription journal moving to full open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Chemical Society
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2018
- ISSN
- 2575-9108
- Latest issue on the website
- Volume 9, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ACS Pharmacology & Translational Science
What CAS zone is ACS Pharmacology & Translational Science in?
In the 2025 upgraded edition of the CAS Journal Ranking, ACS Pharmacology & Translational Science is in Zone 3 of Medicine, and in Zone 3 of the minor category Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ACS Pharmacology & Translational Science?
The journal's website gives an impact factor of 4; this is the journal's own figure, as LetPub lists none for it; CiteScore 5.2, h-index 64.
How long does peer review take at ACS Pharmacology & Translational Science?
Based on the dates recorded on 120 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 67–148 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ACS Pharmacology & Translational Science?
According to LetPub and DOAJ records, ACS Pharmacology & Translational Science is indexed in ESCI and Scopus.
Is ACS Pharmacology & Translational Science open access, and what is the APC?
ACS Pharmacology & Translational Science is a transformative journal. APC about USD 4,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .